We are live on ! Find out more
REGN icon

Regeneron Pharmaceuticals
REGN

1,080 hedge funds and large institutions have $64B invested in Regeneron Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 114 funds opening new positions, 367 increasing their positions, 418 reducing their positions, and 85 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more funds holding in top 10

Funds holding in top 10: 22 → 34 (+12)

34% more first-time investments, than exits

New positions opened: 114 | Existing positions closed: 85

17% more capital invested

Capital invested by funds: $54.7B → $64B (+$9.29B)

2% more funds holding

Funds holding: 1,063 → 1,080 (+17)

0.77% more ownership

Funds ownership: 86.18% → 86.95% (+0.77%)

12% less repeat investments, than reductions

Existing positions increased: 367 | Existing positions reduced: 418

21% less call options, than puts

Call options by funds: $1.17B | Put options by funds: $1.49B

Holders
1,080
Holders Change
+17
Holders Change %
+1.6%
% of All Funds
18.6%
Holding in Top 10
34
Holding in Top 10 Change
+12
Holding in Top 10 Change %
+54.55%
% of All Funds
0.59%
New
114
Increased
367
Reduced
418
Closed
85
Calls
$1.17B
Puts
$1.49B
Net Calls
-$320M
Net Calls Change
-$52.9M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$399M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$261M
3
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$125M
4
WP
Woodline Partners
California
+$84.7M
5
Jane Street
Jane Street
New York
+$69.7M

Top Sellers

1
Harris Associates
Harris Associates
Illinois
-$248M
2
Renaissance Technologies
Renaissance Technologies
New York
-$236M
3
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$112M
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$103M
5
AQR Capital Management
AQR Capital Management
Connecticut
-$75.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
CJL
476
Cyrus J. Lawrence
New York
$1.59M – – –
AA
477
AlphaMark Advisors
Kentucky
$1.58M +$47.2K +75 +3%
OAM
478
Oak Asset Management
California
$1.58M +$1.44M +2,295 New
SWA
479
Stratos Wealth Advisors
Ohio
$1.57M +$203K +322 +16%
PGFC
480
Peapack-Gladstone Financial Corp
New Jersey
$1.57M +$101K +160 +8%
CG
481
Colony Group
Massachusetts
$1.55M -$154K -244 -10%
Fiera Capital (Canada)
482
Fiera Capital (Canada)
Quebec, Canada
$1.54M -$1.26M -2,008 -47%
NEI
483
Northwest & Ethical Investments
Ontario, Canada
$1.53M -$38.4K -61 -3%
BCA
484
Bay Colony Advisors
Massachusetts
$1.53M -$6.29K -10 -0.4%
HWAM
485
Hennion & Walsh Asset Management
New Jersey
$1.52M -$164K -260 -11%
FIM
486
Freedom Investment Management
Connecticut
$1.52M +$146K +232 +12%
NA
487
NewEdge Advisors
Louisiana
$1.52M +$604K +960 +77%
SWM
488
Sculati Wealth Management
Michigan
$1.51M -$6.29K -10 -0.5%
CHAM
489
Clear Harbor Asset Management
Connecticut
$1.5M -$12.6K -20 -0.9%
CPM
490
Connective Portfolio Management
New York
$1.49M +$456K +725 +54%
CIBC World Market
491
CIBC World Market
Ontario, Canada
$1.49M -$1.84M -2,922 -58%
FA
492
FDx Advisors
Illinois
$1.49M -$392K -623 -22%
EFM
493
E Fund Management
China
$1.47M -$30.8K -49 -2%
AWM
494
Ameliora Wealth Management
Switzerland
$1.47M +$1.23M +1,960 +3,439%
CF
495
Centaurus Financial
California
$1.46M +$3.15K +5 +0.2%
Kovitz Investment Group Partners
496
Kovitz Investment Group Partners
Illinois
$1.41M -$343K -545 -21%
V
497
Veritable
Delaware
$1.4M +$99.4K +158 +8%
CAM
498
Cresset Asset Management
Illinois
$1.38M -$18.3K -29 -1%
MA
499
MYDA Advisors
New York
$1.38M +$1.26M +2,000 New
SVWAG
500
Sound View Wealth Advisors Group
Georgia
$1.36M +$39K +62 +3%
18 19
20
21 22

REGN Hedge Fund Activity: Q3 2022 in Review

1,080 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Regeneron Pharmaceuticals (REGN) for Q3 2022, worth a combined $64B — up 17% from $54.7B a quarter earlier.

Buyers outnumbered sellers: 114 funds opened new REGN positions and 85 closed out — a net gain of 29 holders — while 367 added to existing stakes and 418 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $399M. The largest seller was Harris Associates, cutting an estimated $248M.

  • 1,080 institutional investors held Regeneron Pharmaceuticals (REGN) as of Q3 2022, up from 1,063 in Q2 2022.
  • Funds reported $64B of Regeneron Pharmaceuticals stock for Q3 2022, up 17% quarter-over-quarter.
  • 114 funds opened new Regeneron Pharmaceuticals positions in Q3 2022 and 85 closed out, a net change of +29 holders.
  • The largest Regeneron Pharmaceuticals buyer in Q3 2022 was Fidelity Investments, an estimated $399M added.
  • The largest Regeneron Pharmaceuticals seller in Q3 2022 was Harris Associates, an estimated $248M sold.

Based on aggregated 13F filings for Q3 2022.